What is Greenrose Acquisition Corp. (GNRSW)?

Greenrose Acquisition Corp. (GNRSW) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of GNRSW?

The current price of GNRSW is $0.00. Prices are updated in real time on Stocks360.

What is GNRSW's price-to-earnings (PE) ratio?

GNRSW's trailing twelve-month PE ratio is 0.00, based on current price and earnings per share data available on Stocks360.

What is GNRSW's market capitalization?

GNRSW's market capitalization is $1,768.00, placing it in the small-cap tier.

Greenrose Acquisition Corp. (GNRSW)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Market Cap

$1.77K

PE (TTM)

0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

3309.14

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

150.00

Greenrose Acquisition Corp. (GNRSW) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $1.77K. Trailing PE 0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Greenrose Acquisition Corp.

Greenrose Holding Company Inc., operating via its subsidiaries, specializes in the manufacturing and commercialization of cannabis products. Its core business functions include cultivating, processing, and packaging medicinal cannabis and its related derivative items. The organization was established in 2014 and maintains its corporate headquarters in Amityville, New York.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	0.00×
P/S (TTM)	0.00×
P/B	0.00×
PEG	0.00×
P/FCF (TTM)	0.00×
EV / EBITDA	4.37×
EV / Sales	3.99×
Earnings Yield	111616885.17%
Free Cash Flow Yield	149490.95%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$101.42M
Revenue (TTM)	$25.39M
Net Income (TTM)	$1.97B
Free Cash Flow (TTM)	$4.73M
Net Debt	$101.42M
Working Capital	-$103.43M
Gross Margin	59.05%
Operating Margin	38.74%
Net Margin	70.59%
Return on Equity	14.83%
Return on Invested Capital	4.30%